Commentary: Growth-hormone deficiency with children after radiation for brain-tumor - Start substitution fast;Groeihormoondeficientie bij kinderen na bestraling wegens een hersentumor

Nederlands Tijdschrift voor Geneeskunde

Volumn 153, Issue 17, 2009, Pages 792-793

  Bocea, Gianni ^a   Van Beek, Andre P ^a   De Bont, Eveline S J M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILD; DRUG EFFICACY; DRUG SAFETY; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; MEDULLOBLASTOMA; NOTE; QUALITY OF LIFE; TUMOR RECURRENCE; ARTICLE; GROWTH DISORDER; RADIATION RESPONSE; RADIOTHERAPY; TIME;

BRAIN NEOPLASMS; CHILD; DOSE-RESPONSE RELATIONSHIP, RADIATION; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; QUALITY OF LIFE; RADIOTHERAPY; TIME FACTORS;

EID: 67449092175     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Heikens J, Michiels EM, Behrendt H, Endert E, Bakker PJ, Fliers E. Long-term endocrine sequelae after treatment for childhood medulloblastoma. Eur J Cancer. 1998;34:1592-7.
2. Darzy KH, Shalet SM. Pathofysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement. Growth Horm IGF Res. 20o6;i6 suppl A:S30-40.
3. GH Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab. 2000;85:3990-3.
4. Drent ML, Delemarre-van de Waal HA, Wit JM. Eenmaal groeihormoon, altijd groeihormoon? De transitie van groeihormoonbehandeling van kind naar volwassene. Ned Tijdschr Geneeskd. 2002;146:154-7.
5. Sheppard L, Eiser C, Davies HA, Carney S, Clarke SA, Urquhart C, et al. The effects of growth hormone treatment on health-related quality of life in children. Horm Res. 2006;65:243-9-
6. Stouthart PJ, Deijen JB1 Roffel M1 Delemarre-van de Waal HA. Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy. Psychoneuroendocrinology. 2003;28:612-26.
7. Mukherjee A, Tolhurst-Cleaver S, Ryder WD, Smethurst L, Shalet SM. The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy. J Clin Endocrinol Metab. 2005;90:1542-9-
8. Arslanian SA, Becker DJ, Lee PA, Drash AL, Foley TP Jr. Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism. Am J Dis Child. 1985;139:347-50.
9. Packer RJ, Boyett JM, Janss AJ, Stavrou T, Kun L, Wisoff J, et al. Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control. J Clin Oncol. 2001;19:480-7.
10. Blaauwbroek R, Tuinier W, Meyboom-de Jong B, Kamps WA, Postma A. Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study. Lancet Oncol. 2008;9:232-8.